KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer

Cancer Research
Astrid LièvrePierre Laurent-Puig

Abstract

The anti-epidermal growth factor receptor (anti-EGFR) cetuximab has been proven to be efficient in metastatic colorectal cancer. The molecular mechanisms underlying the clinical response to this drug remain unknown. Genetic alterations of the intracellular effectors involved in EGFR-related signaling pathways may have an effect on response to this targeted therapy. In this study, tumors from 30 metastatic colorectal cancer patients treated by cetuximab were screened for KRAS, BRAF, and PIK3CA mutation by direct sequencing and for EGFR copy number by chromogenic in situ hybridization. Eleven of the 30 patients (37%) responded to cetuximab. A KRAS mutation was found in 13 tumors (43%) and was significantly associated with the absence of response to cetuximab (KRAS mutation in 0% of the 11 responder patients versus 68.4% of the 19 nonresponder patients; P = 0.0003). The overall survival of patients without KRAS mutation in their tumor was significantly higher compared with those patients with a mutated tumor (P = 0.016; median, 16.3 versus 6.9 months). An increased EGFR copy number was found in 3 patients (10%) and was significantly associated with an objective tumor response to cetuximab (P = 0.04). In conclusion, in this study, ...Continue Reading

References

May 20, 1998·Journal of the National Cancer Institute·H J AndreyevP A Clarke
Mar 3, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Leonard B SaltzRobert J Mayer
Mar 16, 2004·Science·Yardena SamuelsVictor E Velculescu
Jul 23, 2004·The New England Journal of Medicine·Deborah Schrag
Jul 23, 2004·The New England Journal of Medicine·David CunninghamEric Van Cutsem
Jan 29, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ki Young ChungLeonard B Saltz
Apr 16, 2005·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Jinru ShiaBeiyun Chen
Sep 17, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Shuji OginoCharles S Fuchs

❮ Previous
Next ❯

Citations

Mar 23, 2011·World Journal of Surgery·F Charles BrunicardiChangyi Chen
Mar 17, 2011·Cancer Chemotherapy and Pharmacology·Alfonso De StefanoSabino De Placido
Dec 10, 2009·Der Pathologe·L C Heukamp, R Büttner
Feb 3, 2011·International Journal of Colorectal Disease·Fausto PetrelliSandro Barni
May 7, 2013·International Journal of Colorectal Disease·Yan WangLi-Fang Fan
Oct 18, 2011·International Journal of Clinical Oncology·Toshiaki WatanabeUNKNOWN Japanese Society for Cancer of the Colon and Rectum
May 23, 2008·Breast Cancer Research and Treatment·Maura N DicklerEric P Winer
Apr 23, 2008·Cancer Metastasis Reviews·Mechthild Krause, Michael Baumann
Jun 5, 2013·Cell Biology and Toxicology·Panagiotis J VlachostergiosChristos N Papandreou
Mar 8, 2011·Clinical & Experimental Metastasis·Teodora Evgenieva GoranovaKikuya Kato
Oct 19, 2012·Investigational New Drugs·Naomi WalshNorma O'Donovan
Jun 22, 2010·Molecular Biology Reports·Marta Herreros-VillanuevaMaria Jesus Coma del Corral
Nov 10, 2009·Targeted Oncology·Austin Duffy, Shivaani Kummar
Nov 17, 2009·Targeted Oncology·Fortunato CiardielloDemetris Papamichael
May 7, 2013·Targeted Oncology·Hans PrenenEric Van Cutsem
Jan 15, 2008·Current Treatment Options in Oncology·Crystal S Denlinger, Steven J Cohen
Feb 25, 2009·Current Treatment Options in Oncology·Marwan Fakih
Apr 29, 2010·Current Oncology Reports·Deepa T PatilThomas P Plesec
Mar 5, 2011·Current Oncology Reports·Ben George, Scott Kopetz
Dec 12, 2012·Current Oncology Reports·Emma B Holliday, Erik P Sulman
Nov 18, 2009·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Jose A García-SáenzEduardo Díaz-Rubio García
Jun 11, 2010·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Alejandro RojoJuan F García
Aug 17, 2010·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Jesús García-Foncillas, Eduardo Díaz-Rubio
Mar 23, 2011·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Enrique ArandaEduardo Díaz-Rubio
Oct 7, 2011·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·I JuezJ Figueras
May 1, 2010·Pathology Oncology Research : POR·László Kopper
Jan 15, 2011·Pathology Oncology Research : POR·Yin-Ling MaoYan-Qiao Zhang
Apr 2, 2010·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Marika Nestor
Nov 26, 2010·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Xabier Garcia-AlbenizJoan Maurel
Sep 21, 2013·Cancer Letters·Tze-Kiong ErMarta Herreros-Villanueva
Feb 5, 2013·Cancer Treatment Reviews·Francesco TorinoAngelo Aquino
Sep 10, 2013·Trends in Molecular Medicine·Cristina Migliore, Silvia Giordano

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Rafael G AmadoDavid D Chang
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Astrid LièvrePierre Laurent-Puig
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Shirin Khambata-FordDavid J Mauro
© 2022 Meta ULC. All rights reserved